LATEST UPDATES
CARITAS PHARMA at the XXVII National Congress of the Mexican Transplant Society 2025
CARITAS PHARMA at the LXXI International Congress on Nephrology 2024
CARITAS PHARMA Awarded Two-Star Export House Certification in 2023
CARITAS PHARMA at the XXVI Congress of the Mexican Society of Transplants 2024
CARITAS PHARMA at the 57th National Congress of the Mexican College of Nephrology
Caritas to Participate at CPHI 2025, Frankfurt, Germany
Caritas Honored with Silver Award for Leading Pharmaceuticals Exporter at iPHEX 2025
Caritas Among Distinguished Invitees at iPHEX 2025 Inaugural Session
đ Select Language
English
Español
Home
About Us
Our Story
Brand Promise
Compliance & Ethics
Leadership Team
History & Milestones
Caritas Care
Core Products
Therapeutic Segments/Products
Pharmacovigilance
Our Expertise
Global Pharma Solution Provider
Manufacturing Facilities
Compliance & Regulatory Approvals
Global Logistics
Partnerships
Partnership Overview
For Distributors
For Investors
For Medical Professionals
For Business Inquiry
For Business Partnerships
Connect With Us
Product Brochures
Careers
FAQs
Our Office Locations
Contact For Inquiries
News & Events
Media
+91-79-49132121
FAQs
Home
FAQs
Faqs
What is Caritasâ core business and specialization?
Caritas is a global pharmaceutical company dedicated to the commercialization, registration, and distribution of over 250 high-quality, affordable medicines. Our products cover key therapeutic areas such as Oncology, Renal Care, Anaesthesia, Analgesics Cardiology, Anti-infectives, CNS, Haematology, and an expanding portfolio of biosimilars.
Where does Caritas operate globally?
We have presence in 20+ countries across 5 continents, with subsidiaries in 5 countries and warehousing facilities strategically located in Mexico, Ecuador, and India. This extensive network supports efficient distribution and market access worldwide.
What certifications and quality standards do Caritas manufacturing facilities hold?
Caritas works through a network of six globally certified manufacturing facilities complying with USFDA, EU-GMP, WHO-GMP, ANVISA, MHRA, COFEPRIS, and other international regulatory standards to ensure product safety, efficacy, and quality.
Who are Caritasâ manufacturing and technology partners?
We partner with renowned manufacturers including Dr. Reddyâs, Cadila, Otsuka, Kexing, Umedica, USV, Concord Biotech, and many more â all meeting strict global regulatory requirements â to bring trusted medicines to global markets.
How does Caritas support its partners and distributors?
Caritas offers comprehensive support including regulatory dossier development, market authorization, supply chain management, marketing, sales enablement, warehousing, and pharmacovigilance. Selected partners receive exclusive territorial rights and full commercial backing.
What differentiates Caritas in the pharmaceutical industry?
Our strengths lie in our expansive product portfolio, global regulatory expertise, extensive partner network, robust supply chain, multi-cultural team, and patient centric approach. We combine these with a commitment to accessibility, compliance, and sustainable growth to build trust in global healthcare.
How does Caritas ensure ongoing product quality and patient safety?
Quality is fundamental at Caritas. We implement stringent quality assurance protocols, full regulatory compliance, batch traceability, and continuous pharmacovigilance to maintain the highest standards and ensure patient safety worldwide.
How can interested parties partner or collaborate with Caritas?
We welcome partnerships with distributors, investors, healthcare providers, health systems, and more. To explore collaboration opportunities, please visit our website at www.caritashealthcare.in or contact our headquarters in Ahmedabad, India by dropping us an email at
[email protected]
or call +91-079-4913-2121.